Abstract：Objective To study the composition, abundance, and functional profiles of the intestinal microbiota in infants and young children with Kawasaki disease (KD) during the acute phase, and to explore the potential role of intestinal microbiota in the pathogenesis of KD. Methods Six children aged 0-3 years with acute KD admitted to the Department of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics from July to October 2021 were prospectively included as the KD group. Six age- and sex-matched healthy children who underwent physical examinations at the hospital during the same period were selected as the healthy control group. Metagenomics sequencing was used to detect and compare the differences in the microflora structure and functional profiles of fecal samples between the two groups. Results There were significant differences in the structural composition and diversity of intestinal microbiota between the two groups (P<0.05). Compared with the healthy control group, the abundance of Listeria_monocytogenes (family Listeriaceae and genus Listeria), Bifidobacterium_rousetti, Enterococcus_avium, and Enterococcus_hirae was significantly higher in the intestinal microbiota in the KD group (|LDA|>2.0, P<0.05). The steroid degradation and apoptosis pathways were significantly upregulated in the KD group compared with the healthy control group, while the Bacterial_secretion_system, Sulfur_metabolism, Butanoate_metabolism, Benzoate_degradation, β-alanine metabolism, and α-linolenic acid pathways were significantly downregulated (|LDA|>2, P<0.05). Conclusions There are significant differences in the structure and diversity of intestinal microbiota between children aged 0-3 years with acute KD and healthy children, suggesting that disturbances in intestinal microbiota occur during the acute phase of KD. In particular, Listeria_monocytogenes, Enterococcus_avium, and Enterococcus_hirae may be involved in the pathogenesis of KD through steroid degradation and apoptosis pathways.
WANG Hong-Mao,ZHANG Ming-Ming,LIN Yao et al. Characteristics of intestinal microbiota in the acute phase of Kawasaki disease in infants and children[J]. CJCP, 2024, 26(10): 1101-1107.
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-e999. PMID: 28356445. DOI: 10.1161/CIR.0000000000000484.
Dai Y, Shen Z, Khachatryan LG, et al. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: a comprehensive review[J]. Pathol Res Pract, 2023, 249: 154740. PMID: 37567034. DOI: 10.1016/j.prp.2023.154740.
Felizardo RJF, Watanabe IKM, Dardi P, et al. The interplay among gut microbiota, hypertension and kidney diseases: the role of short-chain fatty acids[J]. Pharmacol Res, 2019, 141: 366-377. PMID: 30639376. DOI: 10.1016/j.phrs.2019.01.019.
Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Kawasaki disease[J]. Arthritis Care Res (Hoboken), 2022, 74(4): 538-548. PMID: 35257507. DOI: 10.1002/acr.24838.
Tamburini S, Shen N, Wu HC, et al. The microbiome in early life: implications for health outcomes[J]. Nat Med, 2016, 22(7): 713-722. PMID: 27387886. DOI: 10.1038/nm.4142.
Milani C, Duranti S, Bottacini F, et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota[J]. Microbiol Mol Biol Rev, 2017, 81(4): e00036-17. PMID: 29118049. PMCID: PMC5706746. DOI: 10.1128/MMBR.00036-17.
Agbavor C, Zimnicka A, Kumar A, et al. The chaperone PrsA2 regulates the secretion, stability, and folding of listeriolysin O during Listeria monocytogenes infection[J]. mBio, 2024, 15(7): e0074324. PMID: 38809022. PMCID: PMC11253611. DOI: 10.1128/mbio.00743-24.
Skrobas U, Zie WS, Bielewicz J, et al. The rapidly progressing and fatal outcome of rhombencephalitis by listeriosis in a 61-year-old male[J]. Ann Agric Environ Med, 2024, 31(2): 311-314. PMID: 38940119. DOI: 10.26444/aaem/178178.
Khan I, Li XA, Law B, et al. Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children[J]. Future Microbiol, 2020, 15: 591-600. PMID: 32490694. DOI: 10.2217/fmb-2019-0301.
